The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
DNA-Damaging Agents in Cancer Chemotherapy: Serendipity and Chemical Biology
Open accessAbstract
DNA-damaging agents have a long history of use in cancer chemotherapy. The full extent of their cellular mechanisms, which is essential to balance efficacy and toxicity, is often unclear. In addition, the use of many anticancer drugs is limited by dose-limiting toxicities as well as the development of drug resistance. Novel anticancer compounds are continually being developed in the hopes of addressing these limitations; however, it is essential to be able to evaluate these compounds for their mechanisms of action. This review covers the current DNA-damaging agents used in the clinic, discusses their limitations, and describes the use of chemical genomics to uncover new information about the DNA damage response network and to evaluate novel DNA-damaging compounds.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
The resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
Functional profiling of the Saccharomyces cerevisiae genome
Giaever, G., Chu, A. M., Ni, L., Connelly, C., Riles, L., Véronneau, S., Dow, S., Lucau-Danila, A., Anderson, K., André, B., et al. (2002) · Nature · doi:10.1038/nature00935 · Cited by 4,316
Self-citationFunctional Characterization of the S. cerevisiae Genome by Gene Deletion and Parallel Analysis
Winzeler, E. A., Shoemaker, D. D., Astromoff, A., Liang, H., Anderson, K., Andre, B., Bangham, R., Benito, R., Boeke, J. D., Bussey, H., et al. (1999) · Science · doi:10.1126/science.285.5429.901 · Cited by 3,953
Self-citationCellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,778
Hannon, G. J. (2002) · Nature · doi:10.1038/418244a · Cited by 3,538
Cisplatin: mode of cytotoxic action and molecular basis of resistance
Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode
ROSENBERG, B., VAN CAMP, L., & KRIGAS, T. (1965) · Nature · doi:10.1038/205698a0 · Cited by 3,049
Mechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643
Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.
Hsiang, Y. H., Hertzberg, R., Hecht, S., & Liu, L. F. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38654-4 · Cited by 2,362
Swain, S. M., Whaley, F. S., & Ewer, M. S. (2003) · Cancer · doi:10.1002/cncr.11407 · Cited by 2,313
The Genetic Landscape of a Cell
Costanzo, M., Baryshnikova, A., Bellay, J., Kim, Y., Spear, E. D., Sevier, C. S., Ding, H., Koh, J. L. Y., Toufighi, K., Mostafavi, S., et al. (2010) · Science · doi:10.1126/science.1180823 · Cited by 2,162
Self-citationChemotherapy and the war on cancer
Chabner, B. A., & Roberts, T. G. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1529 · Cited by 2,154
Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
Heitman, J., Movva, N. R., & Hall, M. N. (1991) · Science · doi:10.1126/science.1715094 · Cited by 2,006
Targeting DNA Double-Strand Breaks with TAL Effector Nucleases
Christian, M., Cermak, T., Doyle, E. L., Schmidt, C., Zhang, F., Hummel, A., Bogdanove, A. J., & Voytas, D. F. (2010) · Genetics · doi:10.1534/genetics.110.120717 · Cited by 1,869
Farber, S., Diamond, L. K., Mercer, R. D., Sylvester, R. F., & Wolff, J. A. (1948) · New England Journal of Medicine · doi:10.1056/nejm194806032382301 · Cited by 1,806
A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen
Moffat, J., Grueneberg, D. A., Yang, X., Kim, S. Y., Kloepfer, A. M., Hinkle, G., Piqani, B., Eisenhaure, T. M., Luo, B., Grenier, J. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.040 · Cited by 1,798
The status of platinum anticancer drugs in the clinic and in clinical trials
Wheate, N. J., Walker, S., Craig, G. E., & Oun, R. (2010) · Dalton Transactions · doi:10.1039/c0dt00292e · Cited by 1,634
Doxorubicin: The good, the bad and the ugly effect
Carvalho, C., Santos, R., Cardoso, S., Correia, S., Oliveira, P., Santos, M., & Moreira, P. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788803312 · Cited by 1,509 · cited 1×
“…explanations for doxorubicin toxicity include inhibition of nucleic acid and protein synthesis, release of vasoactive amines, alterations in adrenergic function and adenylate cyclase activity, changes in calcium transport, and alterations in cellular iron metabolism (Carvalho et al., 2009).”
BackgroundModelling schizophrenia using human induced pluripotent stem cells
Brennand, K. J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., Li, Y., Mu, Y., Chen, G., Yu, D., et al. (2011) · Nature · doi:10.1038/nature09915 · Cited by 1,375
New trends for metal complexes with anticancer activity
Bruijnincx, P. C., & Sadler, P. J. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.11.013 · Cited by 1,306
Cisplatin Nephrotoxicity: A Review
Yao, X., Panichpisal, K., Kurtzman, N., & Nugent, K. (2007) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31812dfe1e · Cited by 1,251
Genome Engineering With Zinc-Finger Nucleases
Carroll, D. (2011) · Genetics · doi:10.1534/genetics.111.131433 · Cited by 1,076
A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene
Luo, J., Emanuele, M. J., Li, D., Creighton, C. J., Schlabach, M. R., Westbrook, T. F., Wong, K.-K., & Elledge, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.05.006 · Cited by 1,017
The Chemical Genomic Portrait of Yeast: Uncovering a Phenotype for All Genes
Hillenmeyer, M. E., Fung, E., Wildenhain, J., Pierce, S. E., Hoon, S., Lee, W., Proctor, M., St.Onge, R. P., Tyers, M., Koller, D., et al. (2008) · Science · doi:10.1126/science.1150021 · Cited by 1,003
Self-citationTewey, K. M., Chen, G. L., Nelson, E. M., & Liu, L. F. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)47282-6 · Cited by 887
Yeast Cells Provide Insight into Alpha-Synuclein Biology and Pathobiology
Outeiro, T. F., & Lindquist, S. (2003) · Science · doi:10.1126/science.1090439 · Cited by 806
Šimůnek, T., Štěrba, M., Popelová, O., Adamcová, M., Hrdina, R., & Geršl, V. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70018-0 · Cited by 769
Takahara, P. M., Rosenzweig, A. C., Frederick, C. A., & Lippard, S. J. (1995) · Nature · doi:10.1038/377649a0 · Cited by 769
Analysis of a genome-wide set of gene deletions in the fission yeast Schizosaccharomyces pombe
Kim, D.-U., Hayles, J., Kim, D., Wood, V., Park, H.-O., Won, M., Yoo, H.-S., Duhig, T., Nam, M., Palmer, G., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1628 · Cited by 742
The Biological Actions and Therapeutic Applications of the B-Chloroethyl Amines and Sulfides
Gilman, A., & Philips, F. S. (1946) · Science · doi:10.1126/science.103.2675.409 · Cited by 732
GOODMAN, L. S. (1946) · Journal of the American Medical Association · doi:10.1001/jama.1946.02870380008004 · Cited by 700
Doxorubicin cardiotoxicity: analysis of prevailing hypotheses
Olson, R. D., & Mushlin, P. S. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.13.2210154 · Cited by 690
Rixe, O., Ortuzar, W., Alvarez, M., Parker, R., Reed, E., Paull, K., & Fojo, T. (1996) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)81490-6 · Cited by 615
Cellular and molecular pharmacology of oxaliplatin.
Raymond, É., Faivre, S. J., Chaney, S. G., WOYNAROWSKI, J. M., & Cvitkovic, E. (2002) · PubMed · Cited by 576
Genomic profiling of drug sensitivities via induced haploinsufficiency
Giaever, G., Shoemaker, D. D., Jones, T. W., Liang, H., Winzeler, E. A., Astromoff, A., & Davis, R. W. (1999) · Nature Genetics · doi:10.1038/6791 · Cited by 570
Self-citationHertzberg, R. P., Caranfa, M. J., & Hecht, S. M. (1989) · Biochemistry · doi:10.1021/bi00437a018 · Cited by 551
Highly parallel identification of essential genes in cancer cells
Luo, B., Cheung, H. W., Subramanian, A., Sharifnia, T., Okamoto, M., Yang, X., Hinkle, G., Boehm, J. S., Beroukhim, R., Weir, B. A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810485105 · Cited by 547
Topoisomerase Poisons: Harnessing the Dark Side of Enzyme Mechanism
Froelich-Ammon, S. J., & Osheroff, N. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.21429 · Cited by 505
Chemogenomic profiling: Identifying the functional interactions of small molecules in yeast
Giaever, G., Flaherty, P., Kumm, J., Proctor, M., Nislow, C., Jaramillo, D. F., Chu, A. M., Jordan, M. I., Arkin, A. P., & Davis, R. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307490100 · Cited by 504
Self-citationTkach, J. M., Yimit, A., Lee, A. Y., Riffle, M., Costanzo, M., Jaschob, D., Hendry, J. A., Ou, J., Moffat, J., Boone, C., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2549 · Cited by 492
Self-citationChen, G. L., Yang, L., Rowe, T. C., Halligan, B. D., Tewey, K. M., & Liu, L. F. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90729-5 · Cited by 492
Haploid Genetic Screens in Human Cells Identify Host Factors Used by Pathogens
Carette, J. E., Guimaraes, C. P., Varadarajan, M., Park, A. S., Wuethrich, I., Godarova, A., Kotecki, M., Cochran, B. H., Spooner, E., Ploegh, H. L., et al. (2009) · Science · doi:10.1126/science.1178955 · Cited by 489
Lum, P. Y., Armour, C. D., Stepaniants, S. B., Cavet, G., Wolf, M. K., Butler, J. S., Hinshaw, J. C., Garnier, P., Prestwich, G. D., Leonardson, A., et al. (2004) · Cell · doi:10.1016/s0092-8674(03)01035-3 · Cited by 481
Botstein, D., Chervitz, S. A., & Cherry, M. (1997) · Science · doi:10.1126/science.277.5330.1259 · Cited by 474
Metabolism and mechanism of action of 5-fluorouracil
Parker, W. B., & Cheng, Y. C. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90056-8 · Cited by 451
Rewiring of Genetic Networks in Response to DNA Damage
Bandyopadhyay, S., Mehta, M., Kuo, D., Sung, M.-K., Chuang, R., Jaehnig, E. J., Bodenmiller, B., Licon, K., Copeland, W., Shales, M., et al. (2010) · Science · doi:10.1126/science.1195618 · Cited by 447 · cited 1×
“Bandyopadhyay et al. (2010) adapted the drug-treated double mutant approach to a colony-based readout, which they called differential epistatic miniarray profiling, which, similar to the St. Onge et al. study, quantifies genetic interactions between pairs of genes and compares the results of two…”
ResultTHE MECHANISM OF COLCHICINE INHIBITION OF MITOSIS
Taylor, E. W. (1965) · The Journal of Cell Biology · doi:10.1083/jcb.25.1.145 · Cited by 421
Adriamycin-induced oxidative mitochondrial cardiotoxicity
Berthiaume, J. M., & Wallace, K. B. (2007) · Cell Biology and Toxicology · doi:10.1007/s10565-006-0140-y · Cited by 409
The influence of structure on the activity and toxicity of Pt anti-cancer drugs
Hambley, T. W. (1997) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(97)00023-4 · Cited by 348
The initial clinical trial of nitrogen mustard
Gilman, A. (1963) · The American Journal of Surgery · doi:10.1016/0002-9610(63)90232-0 · Cited by 338
Smogorzewska, A., Desetty, R., Saito, T. T., Schlabach, M., Lach, F. P., Sowa, M. E., Clark, A. B., Kunkel, T. A., Harper, J. W., Colaiácovo, M. P., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.023 · Cited by 334
Chemical genetic discovery of targets and anti-targets for cancer polypharmacology
Dar, A. C., Das, T. K., Shokat, K. M., & Cagan, R. L. (2012) · Nature · doi:10.1038/nature11127 · Cited by 333
Solution Structure of a Cisplatin-Induced DNA Interstrand Cross-Link
Huang, H., Zhu, L., Reid, B. R., Drobny, G. P., & Hopkins, P. B. (1995) · Science · doi:10.1126/science.270.5243.1842 · Cited by 314
Systematic pathway analysis using high-resolution fitness profiling of combinatorial gene deletions
Onge, R. P. S., Mani, R., Oh, J., Proctor, M., Fung, E., Davis, R. W., Nislow, C., Roth, F. P., & Giaever, G. (2007) · Nature Genetics · doi:10.1038/ng1948 · Cited by 309
Self-citationChang, M., Bellaoui, M., Boone, C., & Brown, G. W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262669299 · Cited by 301
Topoisomerase levels determine chemotherapy response in vitro and in vivo
Burgess, D. J., Doles, J., Zender, L., Xue, W., Ma, B., McCombie, W. R., Hannon, G. J., Lowe, S. W., & Hemann, M. T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803513105 · Cited by 300
Quantitative phenotyping via deep barcode sequencing
Smith, A. M., Heisler, L. E., Mellor, J., Kaper, F., Thompson, M. J., Chee, M., Roth, F. P., Giaever, G., & Nislow, C. (2009) · Genome Research · doi:10.1101/gr.093955.109 · Cited by 298
Self-citationA Systems Approach to Mapping DNA Damage Response Pathways
Workman, C. T., Mak, H. C., McCuine, S., Tagne, J.-B., Agarwal, M., Ozier, O., Begley, T. J., Samson, L. D., & Ideker, T. (2006) · Science · doi:10.1126/science.1122088 · Cited by 268
Complexes of metals other than platinum as antitumour agents
K�pf-Maier, P. (1994) · European Journal of Clinical Pharmacology · doi:10.1007/bf00193472 · Cited by 261
Doxorubicin hepatotoxicity and hepatic free radical metabolism in rats
Kalender, Y., Yel, M., & Kalender, S. (2005) · Toxicology · doi:10.1016/j.tox.2004.12.003 · Cited by 247
Wozniak, A. J., & Ross, W. E. (1983) · PubMed · Cited by 240
Adriamycin-induced, TNF-α-mediated central nervous system toxicity
Tangpong, J., Cole, M. P., Sultana, R., Joshi, G., Estus, S., Vore, M., St. Clair, W., Ratanachaiyavong, S., St. Clair, D. K., & Butterfield, D. A. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.013 · Cited by 238
(1949) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1949.tb68027.x · Cited by 215
Cancer: an old disease, a new disease or something in between?
David, A. R., & Zimmerman, M. R. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2914 · Cited by 214
FARBER, S. (1949) · Blood · doi:10.1182/blood.v4.2.160.160 · Cited by 209
An integrated platform of genomic assays reveals small-molecule bioactivities
Hoon, S., M Smith, A., Wallace, I. M., Suresh, S., Miranda, M., Fung, E., Proctor, M., Shokat, K. M., Zhang, C., Davis, R. W., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.100 · Cited by 201
Self-citationHolford, J., Sharp, S., Murrer, B., Abrams, M., & Kelland, L. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.59 · Cited by 196
Therapy of Choriocarcinoma and Related Trophoblastic Tumors with Folic Acid and Purine Antagonists
Li, M. C., Hertz, R., & Bergenstal, D. M. (1958) · New England Journal of Medicine · doi:10.1056/nejm195807102590204 · Cited by 189
A genome-wide screen in Saccharomyces cerevisiae for genes affecting UV radiation sensitivity
Birrell, G. W., Giaever, G., Chu, A. M., Davis, R. W., & Brown, J. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231366398 · Cited by 178
Self-citationCross‐species chemogenomic profiling reveals evolutionarily conserved drug mode of action
Kapitzky, L., Beltrao, P., Berens, T. J., Gassner, N., Zhou, C., Wüster, A., Wu, J., Babu, M. M., Elledge, S. J., Toczyski, D., et al. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.107 · Cited by 170
The Power and Potential of Doxorubicin‐DNA Adducts
Cutts, S. M., Nudelman, A., Rephaeli, A., & Phillips, D. R. (2005) · IUBMB Life · doi:10.1080/15216540500079093 · Cited by 168
Genome-Wide Requirements for Resistance to Functionally Distinct DNA-Damaging Agents
Lee, W., St.Onge, R. P., Proctor, M., Flaherty, P., Jordan, M. I., Arkin, A. P., Davis, R. W., Nislow, C., & Giaever, G. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010024 · Cited by 164
Self-citationshRNA libraries and their use in cancer genetics
Bernards, R., Brummelkamp, T. R., & Beijersbergen, R. L. (2006) · Nature Methods · doi:10.1038/nmeth921 · Cited by 159
The MMS22L-TONSL Complex Mediates Recovery from Replication Stress and Homologous Recombination
O'Donnell, L., Panier, S., Wildenhain, J., Tkach, J. M., Al-Hakim, A., Landry, M.-C., Escribano-Diaz, C., Szilard, R. K., Young, J. T. F., Munro, M., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.024 · Cited by 149 · cited 2×
“An independent study also identified MMS22L and NFKBIL2 (TONSL) in an RNAi-based screen to identify siRNAs that lead to increased 53BP1 subnuclear foci formation in response to ionizing radiation (O’Donnell et al., 2010).”
BackgroundAn in vivo large-scale chemical screening platform using Drosophila for anti-cancer drug discovery
Willoughby, L. F., Schlosser, T., Manning, S. A., Parisot, J. P., Street, I. P., Richardson, H. E., Humbert, P. O., & Brumby, A. M. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.009985 · Cited by 136
O'Connell, B. C., Adamson, B., Lydeard, J. R., Sowa, M. E., Ciccia, A., Bredemeyer, A. L., Schlabach, M., Gygi, S. P., Elledge, S. J., & Harper, J. W. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.022 · Cited by 122
AML1-ETO reprograms hematopoietic cell fate by downregulatingsclexpression
Yeh, J.-R. J., Munson, K. M., Chao, Y. L., Peterson, Q. P., MacRae, C. A., & Peterson, R. T. (2007) · Development · doi:10.1242/dev.008904 · Cited by 121
A unique and universal molecular barcode array
Pierce, S. E., Fung, E., Jaramillo, D. F., Chu, A. M., Davis, R. W., Nislow, C., & Giaever, G. N. (2006) · Nature Methods · doi:10.1038/nmeth905 · Cited by 111
Self-citationBaruah, H., Barry, C. G., & Bierbach, U. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043387313 · Cited by 108
The yeasts Saccharomyces cerevisiae and Schizosaccharomyces pombe: models for cell biology research.
Forsburg, S. L. (2005) · PubMed · Cited by 96
KRUMBHAAR, E. B., & Krumbhaar, H. D. (1919) · PubMed · Cited by 85
Deshpande, G., Hayles, J., Hoe, K., Kim, D.-U., Park, H.-O., & Hartsuiker, E. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.01.016 · Cited by 84
Fischhaber, P. L., Gall, A., Duncan, J. A., et al. (1999) · PubMed · Cited by 81
Chemical genetics and drug screening in Drosophila cancer models
Gladstone, M. N., & Su, T. T. (2011) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2011.09.003 · Cited by 69
Gagnon, V., St-Germain, M.-É., Descôteaux, C., Provencher-Mandeville, J., Parent, S., Mandal, S. K., Asselin, É., & Bérubé, G. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.09.015 · Cited by 55
RNAi Codex: a portal/database for short-hairpin RNA (shRNA) gene-silencing constructs
Olson, A. J., Sheth, N., Lee, J. S., Hannon, G., & Sachidanandam, R. (2005) · Nucleic Acids Research · doi:10.1093/nar/gkj051 · Cited by 53
Compound Prioritization Methods Increase Rates of Chemical Probe Discovery in Model Organisms
Wallace, I. M., Urbanus, M. L., Luciani, G. M., Burns, A. R., Han, M. K. L., Wang, H., Arora, K., Heisler, L. E., Proctor, M. J., St.Onge, R. P., et al. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.07.018 · Cited by 46
Self-citationCheung-Ong, K., Song, K., Ma, Z., Shabtai, D., Lee, A. Y., Gallo, D., Heisler, L. E., Brown, G. W., Bierbach, U., Giaever, G. N., et al. (2012) · ACS Chemical Biology · doi:10.1021/cb300320d · Cited by 43
Self-citationA comprehensive platform for highly multiplexed mammalian functional genetic screens
Ketela, T., Heisler, L. E., Brown, K. R., Ammar, R., Kasimer, D., Surendra, A., Ericson, E., Blakely, K. M., Karamboulas, D., Smith, A. M., et al. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-213 · Cited by 42
Self-citationPan, X. M., Lei, B., Zhou, N., Feng, B.-W., Yao, W., Zhao, X., Yu, Y., & Lü, H. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-662 · Cited by 33
A review of selected anti-tumour therapeutic agents and reasons for multidrug resistance occurrence
Sawicka, M., Kalinowska, M., Skierski, J., et al. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357044265 · Cited by 31
One step forward: The use of transgenic zebrafish tumor model in drug screens
Huang, X., Nguyễn, A. T., Li, Z., Emelyanov, A., Parinov, S., & Gong, Z. (2011) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.20208 · Cited by 18
Cited by
Antibody drug conjugate: the “biological missile” for targeted cancer therapy
Fu, Z., Li, S., Han, S., Shi, C., & Zhang, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00947-7 · Cited by 1,643
Senescent cells: an emerging target for diseases of ageing
Childs, B. G., Gluscevic, M., Baker, D. J., Laberge, R.-M., Marquess, D., Dananberg, J., & van Deursen, J. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.116 · Cited by 1,284
Nunes, A. S., Barros, A. S., Costa, E. C., Moreira, A. F., & Correia, I. J. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.26845 · Cited by 721
BRD4 and Cancer: going beyond transcriptional regulation
Donati, B., Lorenzini, E., & Ciarrocchi, A. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0915-9 · Cited by 708
Emran, T. B., Shahriar, A., Mahmud, A. R., Rahman, T., Abir, M. H., Siddiquee, M. F. R., Ahmed, H., Rahman, N., Nainu, F., Wahyudin, E., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.891652 · Cited by 606
Metadata
- Authors
- Cheung-Ong, K., Giaever, G., & Nislow, C.
- Venue
- Chemistry & Biology
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 20
- Issue
- 5
- Pages
- 648-659
- ISSN
- 1074-5521 (ISSN-L)
- OpenAlex
- W1966834115
- Cited by
- 591
- References
- 95
- FWCI
- 11.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.